分子生物学
IVD分子诊断
细胞培养与分析
蛋白研究
细胞因子
重组蛋白
抗体
高通量测序建库
病原检测UCF系列
生物医药
工具酶
抑制剂激活剂与常用试剂
仪器
耗材

Detection of a novel PAX6 variant in a Chinese family with multiple ocular abnormalities

Ouyang Junyi, Cai Ziyan, Guo Yinjie, Nie Fen, Cao Mengdan, Duan Xuanchu

Journal:BMC Ophthalmology

IF:2.09

DOI:10.1186/s12886-022-02256-7

PMID:35034608

Published:2022-01-16

research field:肿瘤学乳腺癌研究药理学细胞生物学分子肿瘤学天然产物化学

Abstract

Background Aniridia is a congenital, panocular disease that can affect the cornea, anterior chamber angle, iris, lens, retina and optic nerve. PAX6 loss-of-function variants are the most common cause of aniridia, and variants throughout the gene have been linked to a range of ophthalmic abnormalities. Furthermore, particular variants at a given site in PAX6 lead to distinct phenotypes. This study aimed to characterize genetic variants associated with congenital aniridia in a Chinese family.Methods The proband and family underwent ophthalmologic examinations. DNA was sampled from the peripheral blood of all 6 individuals, and whole-exome sequencing was performed. Sanger sequencing was used to verify the variant in this family members.Results A novel variant (c.114_119delinsAATTTCC: p.Pro39llefsTer17) in the PAX6 gene was identified in subjects II-1, III-1 and III-2, who exhibited complete aniridia and cataracts. The proband and the proband’s brother also had glaucoma, high myopia, and foveal hypoplasia.Conclusion sWe identified that a novel PAX6 frameshift heterozygous deletion variant is the predominant cause of aniridia in this Chinese family.Trial registrationWe did not perform any health-related interventions for the participants.

本文使用的Yeasen产品

购物车
客服
转染试用